Billing and Coding: MolDX: Proteomics Testing (A59641) - R4 - Effective May 30, 2024

Date Posted: May 30, 2024

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Effective Date: May 30, 2024

Summary of Article Changes:

Under Article Text 6th paragraph added sentence "MolDX is delaying enforcement for changes to reimbursement until 1/31/2025". This revision is in response to feedback received from clinical laboratories and is effective 5/30/2024.

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

Last Updated May 30 , 2024